Mesa Laboratories, Inc.

Historical 13F Holders

Symbol
MLAB
CUSIP
59064R109
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 59064R109 since 12/18/2024, largest first.

Filer % of Class Filed
Conestoga Capital Advisors, LLC 13G/A
11.4% 1/10/2025
Event 12/31/2024
Long Path Smaller Companies Fund, LP 13G/A
8.6% 7/7/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 7.9% 10/27/2026
Event 9/30/2026
Wasatch Advisors LP 13G 6.9% 10/9/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Royce & Associates LP 13G/A 4.99% 4/30/2025
Event 3/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 184 5.56 M $723M
2026 Q2 159 5.03 M $501M
2026 Q1 161 4.83 M $427M
2025 Q4 159 4.74 M $372M
2025 Q3 141 4.98 M $334M
2025 Q2 157 5.19 M $489M
2025 Q1 153 5.17 M $613M
2024 Q4 159 5.10 M $673M
2024 Q3 168 4.89 M $633M
2024 Q2 157 4.89 M $425M
2024 Q1 156 4.87 M $534M
2023 Q4 161 4.84 M $507M
2023 Q3 157 4.92 M $515M
2023 Q2 163 4.88 M $630M
2023 Q1 162 5.02 M $879M
2022 Q4 162 5.08 M $847M
2022 Q3 166 4.84 M $681M
2022 Q2 176 4.91 M $1.00B
2022 Q1 176 4.86 M $1.24B
2021 Q4 179 4.79 M $1.57B
2021 Q3 173 4.77 M $1.44B
2021 Q2 160 4.71 M $1.28B
2021 Q1 174 4.61 M $1.12B
2020 Q4 176 4.71 M $1.35B
2020 Q3 154 4.78 M $1.22B
2020 Q2 170 4.67 M $1.01B
2020 Q1 146 4.16 M $940M
2019 Q4 152 4.04 M $1.01B
2019 Q3 145 3.98 M $945M
2019 Q2 126 3.54 M $865M
2019 Q1 123 2.85 M $656M
2018 Q4 110 2.95 M $615M
2018 Q3 108 2.71 M $504M
2018 Q2 107 2.78 M $586M
2018 Q1 91 2.80 M $416M
2017 Q4 93 2.72 M $338M
2017 Q3 101 2.64 M $394M
2017 Q2 90 2.52 M $362M
2017 Q1 88 2.42 M $297M
2016 Q4 86 2.37 M $291M
2016 Q3 81 2.32 M $265M
2016 Q2 81 2.26 M $278M
2016 Q1 72 2.32 M $224M
2015 Q4 69 2.20 M $219M
2015 Q3 65 2.14 M $238M
2015 Q2 69 2.09 M $186M
2015 Q1 61 2.03 M $146M
2014 Q4 60 1.95 M $151M
2014 Q3 58 1.71 M $99.1M
2014 Q2 65 1.88 M $158M
2014 Q1 66 1.84 M $166M